Specifically, following chemotherapy, dying cancer cells release immunostimulatory molecules such as ATP, calreticulin and High Mobility Group Box 1 (HMGB1), collectively known as Damage‐Associated Molecular Patterns (DAMPs). Here, HMGB1 is linked to cancer.